Florida-based Medical Weight Loss Franchise Grows to Answer National Demand in Fight Against the Lingering Impact of the Pandemic ST. PETERSBURG, Fla. , May 21, 2021 /PRNewswire-PRWeb/ -- Options Medical Weight Loss, a successful medical ...
BAGSVÆRD, Denmark , May 13, 2021 /PRNewswire/ -- Novo Nordisk today announced new results from the STEP phase 3a clinical trial programme, demonstrating potential benefits beyond weight loss for people with obesity being treated with ...
Southern California-based West Medical comments on a recent article that weight loss procedures make defeating obesity possible for a great many patients. LOS ANGELES , May 7, 2021 /PRNewswire-PRWeb/ -- An April 20 article on UPI ...
The World Gastroenterology Organisation (WGO), together with the International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO) have partnered to bring awareness to the 2021 World Digestive Health Dave theme entitled Obesity: An ...
West Medical comments on a recent article that obesity should be considered a treatable medical condition rather than a matter of willpower. LOS ANGELES , March 25, 2021 /PRNewswire-PRWeb/ -- A February 26 article on NPR reports on ...
BOSTON , March 17, 2021 /PRNewswire/ -- ERX Pharmaceuticals , a biopharmaceutical company developing a first-in-class leptin sensitizer to treat obesity is moving forward with next stage of their FDA approved Phase 1 study evaluating ...
Pumpkin Pet Insurance Provides Top Tips for Owners to Help Overweight Dogs NEW YORK , March 10, 2021 /PRNewswire-PRWeb/ -- Pet obesity is a serious health threat to roughly 25-30% of beloved household dogs. Most often caused by excessive ...
In February 2021, Novo Nordisk released impressive data from its Phase IIIa STEP1 trial for semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist, in a bid to strengthen its position as the market leader in obesity. There is a clear unmet ...
After 7 days, CurraNZ was found to help reduce obesity driven inflammation by 24% and whole-body insulin sensitivity by 22%1 LONDON , March 2, 2021 /PRNewswire/ -- With experts claiming Britain's obesity and Diabetes crisis as one of the ...
After 7 days, CurraNZ was found to help reduce obesity driven inflammation by 24% and whole-body insulin sensitivity by 22%1 LONDON , March 2, 2021 /PRNewswire/ -- With experts claiming Britain's obesity and Diabetes crisis as one of the ...
Mayo Clinic’s latest study demonstrates that laparoscopic sleeve gastrectomy accelerates weight reduction, diminishes obesity-linked health complications, and enhances the possibility of kidney transplant qualification for individuals with severe ...
Nerve-stimulation treatment for obstructive sleep apnea is now accessible to severely obese patients with BMIs up to 40, marking a significant expansion beyond the conventional healthy BMI range of 18.5 to 24.9. ...
Childhood obesity not only doubles but more than doubles the risk of future multiple sclerosis —a chilling revelation underscoring the urgent need for proactive measures to combat this alarming health trajectory. The study is by Professor Claude ...
Novel findings on natural appetite modulation offer hope for combating obesity and type-2 diabetes as per a study by scientists from Trinity College Dublin and Princeton and Harvard Medical School, published in the leading international journal ...
Doctors state that childhood obesity in India has surged significantly, leading to an unhealthy future for these children . World Obesity Day ( ) is observed every year on March 4 to raise awareness about the condition and its implications.“As a consultant ...
Subscribe to our Free Newsletters!
Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment.
Full Disclaimer
Advertise with us | Medindia Copyright | Privacy Policy | Terms of Use © All Rights Reserved 1997 - 2024
Careers